Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-25-003774

Chief Commercial Officer sold 12,991 shares at $0.57 ($7,467)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Piccina Cintia Chief Commercial Officer 2025-01-15 Sale −12,991 $0.57 $7,467 18,421 D
Open-market sales · 12,991 sh · avg $0.57 · $7,467
Loading xslF345X05/tm253441-4_4seq1.xml…